[{"address1": "201 Brookline Avenue", "address2": "Suite 901", "city": "Boston", "state": "MA", "zip": "02215", "country": "United States", "phone": "857 320 4900", "website": "https://www.tangotx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company develops TNG462, an oral small molecule methylthioadenosine-cooperative inhibitor for the treatment for cancers with methylthioadenosine phosphorylase deletions; TNG260, a co-repressor of repressor element-1 silencing transcription -selective inhibitor; TNG348, an ubiquitin-specific protease 1 inhibitor to treat patients with BRCA1 or BRCA2-mutant cancers; and Target 3 for STK11-mutant cancers. It has a strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer. Tango Therapeutics, Inc. was founded in 2017 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 155, "companyOfficers": [{"maxAge": 1, "name": "Dr. Barbara L. Weber M.D.", "age": 67, "title": "President, CEO & Director", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 1039811, "exercisedValue": 0, "unexercisedValue": 9991192}, {"maxAge": 1, "name": "Dr. Adam S. Crystal M.D., Ph.D.", "age": 47, "title": "President of Research & Development", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 977216, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alan  Ashworth FRS, Ph.D.", "age": 62, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1962, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William G. Kaelin Jr., M.D.", "age": 66, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1958, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Antoni  Ribas M.D., Ph.D.", "age": 56, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Timothy  Redfern", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1979, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Palmieri Ph.D.", "title": "Head of Technical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jannik N. Andersen Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Douglas J. Barry Esq., J.D.", "age": 54, "title": "Chief Legal Officer, Chief Compliance Officer & Corporate Secretary", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Julie  Carretero", "age": 52, "title": "Chief Human Resources Officer", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 4, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.11, "open": 2.11, "dayLow": 2.0, "dayHigh": 2.17, "regularMarketPreviousClose": 2.11, "regularMarketOpen": 2.11, "regularMarketDayLow": 2.0, "regularMarketDayHigh": 2.17, "payoutRatio": 0.0, "beta": 0.873, "forwardPE": -1.415493, "volume": 645239, "regularMarketVolume": 645239, "averageVolume": 959410, "averageVolume10days": 946990, "averageDailyVolume10Day": 946990, "bid": 1.56, "ask": 2.59, "bidSize": 2, "askSize": 2, "marketCap": 217297072, "fiftyTwoWeekLow": 1.78, "fiftyTwoWeekHigh": 12.015, "priceToSalesTrailing12Months": 5.165254, "fiftyDayAverage": 2.7641, "twoHundredDayAverage": 6.2486, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -4127141, "profitMargins": 0.0, "floatShares": 46645311, "sharesOutstanding": 108108000, "sharesShort": 5942526, "sharesShortPriorMonth": 7019428, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.0552, "heldPercentInsiders": 0.08402, "heldPercentInstitutions": 0.99555, "shortRatio": 9.09, "shortPercentOfFloat": 0.1014, "impliedSharesOutstanding": 108108000, "bookValue": 1.852, "priceToBook": 1.0853132, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -130302000, "trailingEps": -1.19, "forwardEps": -1.42, "enterpriseToRevenue": -0.098, "enterpriseToEbitda": 0.029, "52WeekChange": -0.81284916, "SandP52WeekChange": 0.12744582, "quoteType": "EQUITY", "currentPrice": 2.01, "targetHighPrice": 16.0, "targetLowPrice": 8.0, "targetMeanPrice": 11.5, "targetMedianPrice": 11.5, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 257916992, "totalCashPerShare": 2.386, "ebitda": -143096000, "totalDebt": 36493000, "quickRatio": 6.757, "currentRatio": 6.978, "totalRevenue": 42069000, "debtToEquity": 18.291, "revenuePerShare": 0.385, "returnOnAssets": -0.2531, "returnOnEquity": -0.57576, "grossProfits": -101849000, "freeCashflow": -67267872, "operatingCashflow": -131501000, "revenueGrowth": -0.242, "grossMargins": -2.421, "ebitdaMargins": 0.0, "operatingMargins": -9.93685, "financialCurrency": "USD", "symbol": "TNGX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Tango Therapeutics, Inc.", "longName": "Tango Therapeutics, Inc.", "corporateActions": [], "postMarketTime": 1741394897, "regularMarketTime": 1741381201, "exchange": "NGM", "messageBoardId": "finmb_424111353", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -4.739332, "regularMarketPrice": 2.01, "postMarketChangePercent": 4.97512, "postMarketPrice": 2.11, "postMarketChange": 0.0999999, "regularMarketChange": -0.099999905, "regularMarketDayRange": "2.0 - 2.17", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 959410, "fiftyTwoWeekLowChange": 0.23000002, "fiftyTwoWeekLowChangePercent": 0.1292135, "fiftyTwoWeekRange": "1.78 - 12.015", "fiftyTwoWeekHighChange": -10.005, "fiftyTwoWeekHighChangePercent": -0.8327091, "fiftyTwoWeekChangePercent": -81.28492, "earningsTimestamp": 1740657600, "earningsTimestampStart": 1746534600, "earningsTimestampEnd": 1747053000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.19, "epsForward": -1.42, "epsCurrentYear": -1.29112, "priceEpsCurrentYear": -1.5567878, "fiftyDayAverageChange": -0.7541001, "fiftyDayAverageChangePercent": -0.2728194, "twoHundredDayAverageChange": -4.2386, "twoHundredDayAverageChangePercent": -0.6783279, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1599139800000, "displayName": "Tango Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-08"}]